Literature DB >> 9407367

Reproducibility of retardation measurements with the nerve fiber analyzer II.

L Zangwill1, C A Berry, V S Garden, R N Weinreb.   

Abstract

PURPOSE: To evaluate the reproducibility of a scanning laser polarimeter, the Nerve Fiber Analyzer II (NFA II, Laser Diagnostic Technologies, San Diego, CA, U.S.A.).
METHODS: Five independent retardation maps of the peripapillary retina of five normal eyes were acquired by three experienced operators (including V.S.G.) on each of three separate days for a total of 45 retardation maps per patient. Two methods of image processing, one using a baseline image and another using the individual scans, were used to compare the reproducibility of three summary measures, average retardation, integral, and retardation ratio.
RESULTS: The average standard deviation (and its 95% confidence interval) of average retardation within a 10-pixel-width-band of the 9 baseline images was 0.43 degree (0.36-0.51 degree) with a mean coefficient of variation of 4.2% (3.8-4.5%). In a random effects model, each of the three retinal nerve fiber layer (RNFL) summary measures varied significantly by patient (p < 0.016), but not by operator (p > 0.19), or operator by patient interaction (p > 0.524). In addition, there was small, but statistically significant day-by-operator-within-patient (intraobserver) variation in the random effects model.
CONCLUSIONS: These results suggest that the NFA II provides reproducible measurements and that, on average, measurements obtained by separate operators on different days are similar.

Entities:  

Mesh:

Year:  1997        PMID: 9407367

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  22 in total

1.  Relation of optic disc topography and age to thickness of retinal nerve fibre layer as measured using scanning laser polarimetry, in normal subjects.

Authors:  A B Toprak; O F Yilmaz
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  Asymmetries of the retinal nerve fibre layer thickness in normal eyes.

Authors:  Y Kurimoto; K Matsuno; Y Kaneko; J Umihira; N Yoshimura
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

Review 3.  Laser imaging of the retina.

Authors:  P F Sharp; A Manivannan; P Vieira; J H Hipwell
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

4.  Effects of artefacts on scanning laser polarimetry of retinal nerve fibre layer thickness measurement.

Authors:  S Kogure; T Chiba; T Kinoshita; H Kowa; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

5.  Comparison of algorithms for detection of localised nerve fibre layer defects using scanning laser polarimetry.

Authors:  F A Medeiros; R Susanna
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

Review 6.  Imaging in glaucoma.

Authors:  Daniel M Stein; Gadi Wollstein; Joel S Schuman
Journal:  Ophthalmol Clin North Am       Date:  2004-03

7.  An enhancement module to improve the atypical birefringence pattern using scanning laser polarimetry with variable corneal compensation.

Authors:  M Sehi; D C Guaqueta; D S Greenfield
Journal:  Br J Ophthalmol       Date:  2006-02-15       Impact factor: 4.638

8.  Detection and diagnosis of glaucoma: ocular imaging.

Authors:  Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

9.  Quantitative analysis of axonal loss in band atrophy of the optic nerve using scanning laser polarimetry.

Authors:  M L R Monteiro; F A Medeiros; M R Ostroscki
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

10.  Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study.

Authors:  Masoud Soheilian; Saeed Karimi; Talieh Montahae; Homayoun Nikkhah; Seyed Aliasghar Mosavi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-14       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.